|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||||||||
| Prepaids and other current assets | ||||||||||||||||||
| Total Current Assets | ||||||||||||||||||
| Property, Plant & Equipment (net) | ||||||||||||||||||
| Prepaid Expenses | ||||||||||||||||||
| Total Assets | ||||||||||||||||||
| Current Liabilities | ||||||||||||||||||
| Accrued Liabilities and Other Payable | ||||||||||||||||||
| Accounts Payable and Accrued Expenses | ||||||||||||||||||
| Deferred Revenue | ||||||||||||||||||
| Due to Related Party | ||||||||||||||||||
| Due to related parties | ||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||
| Total Liabilities | ||||||||||||||||||
| Commitments and contingencies | ||||||||||||||||||
| Stockholders' Deficit | ||||||||||||||||||
| Common Stock, $0.001 par value, 75,000,000 shares authorized, and 7,825,000 shares issued and outstanding, respectively | ||||||||||||||||||
| Additional Paid-in Capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||
| Total Liabilities and Stockholders' Deficit | ||||||||||||||||||
Loading...
